Breast Cancer Trials
S1207
S1207 – Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-positive and HER2/Neu negative breast cancer.
-
What type of cancer? What stage?
- Early stage breast cancer – Stage 1, 2, and 3
-
Who is eligible?
- Women who are ER/PR+ but Her2-
-
How will I be treated?
- Women may also receive Everolimus – an mTOR inhibitor
A5481082
A5481082 – Palbociclib in hormone receptor positive advanced breast cancer: a prospective multi center non-interventional study
-
What type of cancer? What stage?
- Triple negative breast cancer
-
Who is eligible?
- Women with inoperable or metastatic disease
-
How will I be treated?
- Women may also receive palcociclib (Ibrance), which is used to treat ER+ breast cancer.
For physicians: more information about this specific trial at clinicaltrials.gov.
-
Metairie, LA 70006
504.503.6289 More information -
Metairie, LA 70006
504.456.5000 More information -
Metairie, LA 70006
504.883.2968 More information
/
View All
-
Let’s start with some good news: colorectal cancer diagnoses and mortality rates are on the decline. ...
Continue Reading -
When you own a house, you take care of it with regular maintenance. When you own a car, you take it to ...
Continue Reading
/
View All